Supplementary Table IV.
Country of first author of studies validating artificial intelligence/machine learning protocols in cancer diagnosis
| Country | Number of studies (%) | Country | Number of studies (%) |
|---|---|---|---|
| USA | 72 (32.3) | Austria | 2 (0.9) |
| China | 26 (11.7) | Denmark | 2 (0.9) |
| Germany | 17 (7.6) | Singapore | 2 (0.9) |
| Japan | 12 (5.4) | Spain | 2 (0.9) |
| South Korea | 12 (5.4) | Belgium | 1 (0.4) |
| Italy | 10 (4.5) | Brazil | 1 (0.4) |
| UK | 9 (4.0) | Colombia | 1 (0.4) |
| Taiwan | 7 (3.1) | Czech Republic | 1 (0.4) |
| Canada | 5 (2.2) | Egypt | 1 (0.4) |
| India | 4 (1.8) | Israel | 1 (0.4) |
| Greece | 4 (1.8) | Malaysia | 1 (0.4) |
| The Netherlands | 4 (1.8) | NA | 1 (0.4) |
| Poland | 4 (1.8) | Portugal | 1 (0.4) |
| Switzerland | 4 (1.8) | Serbia | 1 (0.4) |
| Australia | 3 (1.3) | Syria | 1 (0.4) |
| Romania | 3 (1.3) | Tunisia | 1 (0.4) |
| Sweden | 3 (1.3) | Uruguay | 1 (0.4) |
| Turkey | 3 (1.3) | Total | 223 (100) |